| CD133:molecule of the moment d mizrak, m alison journal of pathology, 2008 | 771 | 2008 |
| Clinical Trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis R Idilman, D Mizrak Alimentary Pharmacology & Therapeutics, 2008 | 154 | 2008 |
| Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis G Yildiz, A Arslan-Ergul, S Bagislar, O Konu, H Yuzugullu, ... PloS one 8 (5), e64016, 2013 | 69 | 2013 |
| Global chemotherapy development for gastric cancer K Harada, D Mizrak Kaya, Y Shimodaira, JA Ajani Gastric Cancer 20, 92-101, 2017 | 44 | 2017 |
| Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee … A Alkan, ZG Guc, FC Senler, T Yavuzsen, H Onur, M Dogan, E Karci, ... Supportive Care in Cancer 24, 3747-3755, 2016 | 34 | 2016 |
| Liquid biopsies in gastrointestinal malignancies: when is the big day? A Lopez, K Harada, D Mizrak Kaya, X Dong, S Song, JA Ajani Expert review of anticancer therapy 18 (1), 19-38, 2018 | 32 | 2018 |
| Advanced gastric adenocarcinoma: optimizing therapy options D Mizrak Kaya, K Harada, Y Shimodaira, FG Amlashi, Q Lin, JA Ajani Expert Review of Clinical Pharmacology 10 (3), 263-271, 2017 | 30 | 2017 |
| Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients R Wadhwa, X Wang, V Baladandayuthapani, B Liu, H Shiozaki, ... British Journal of Cancer 117 (5), 648-655, 2017 | 28 | 2017 |
| A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease M Sayki Arslan, S Turhan, I Dincer, D Mizrak, D Corapcioglu, R Idilman Diabetology & metabolic syndrome 6, 1-6, 2014 | 22 | 2014 |
| Aflatoxin exposure in viral hepatitis patients in Turkey D Mizrak, B Engin, F ÖNDER, B Yener, M Bektaş, Z Biyikli, R Idilman, ... Turkish Journal of Gastroenterology 20 (3), 2009 | 21 | 2009 |
| Karaciğer nakli: Hasta seçimi, gelişen endikasyonlar D MIZRAK, R İDİLMAN Turkiye Klinikleri General Surgery-Special Topics 2 (1), 10-13, 2009 | 20 | 2009 |
| Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma D Mizrak Kaya, GM Nogueras‐González, K Harada, FG Amlashi, ... Journal of surgical oncology 117 (4), 678-684, 2018 | 18 | 2018 |
| Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance E Elimova, RS Slack, HC Chen, V Planjery, H Shiozaki, Y Shimodaira, ... Oncotarget 8 (46), 81430, 2017 | 18 | 2017 |
| 101 long-term survivors who had metastatic gastroesophageal cancer and received local consolidative therapy D Mizrak Kaya, X Wang, K Harada, MA Blum Murphy, P Das, BD Minsky, ... Oncology 93 (4), 243-248, 2017 | 15 | 2017 |
| Total lesion glycolysis assessment identifies a patient fraction with a high cure rate among esophageal adenocarcinoma patients treated with definitive chemoradiation K Harada, CC Wu, X Wang, DM Kaya, FG Amlashi, M Iwatsuki, ... Annals of surgery 272 (2), 311-318, 2020 | 13 | 2020 |
| Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: secondary analysis of a randomized trial K Harada, X Wang, Y Shimodaira, T Sagebiel, MS Bhutani, JH Lee, ... Targeted oncology 13, 99-106, 2018 | 13 | 2018 |
| Metastatic gastroesophageal adenocarcinoma patients treated with systemic therapy followed by consolidative local therapy: a nomogram associated with long-term survivors H Shiozaki, RS Slack, HC Chen, E Elimova, V Planjery, N Charalampakis, ... Oncology 91 (1), 55-60, 2016 | 13 | 2016 |
| Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial Y Shimodaira, RS Slack, K Harada, HC Chen, T Sagebiel, MS Bhutani, ... British journal of cancer 118 (3), 331-337, 2018 | 12 | 2018 |
| Docetaxel-induced pericardial effusion SE Dogan, D Mizrak, A Alkan, A Demirkazik Journal of Oncology Pharmacy Practice 23 (5), 389-391, 2017 | 12 | 2017 |
| Systemic immune-inflammation index as a prognostic marker of late recurrence in operable gastric cancer: a dual-center study E Yekedüz, İ Dogan, DM Kaya, İ Özgür, G Utkan, S Vatansever, S Demirci, ... Journal of Gastrointestinal Cancer, 1-10, 2022 | 11 | 2022 |
